Olga Warszawik-Hendzel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Olga Warszawik-Hendzel has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Lidia Rudnicka
Department of Dermatology, Medical University of Warsaw, 02-006 Warsaw, Poland
3 shared publications - Małgorzata Olszewska
Department of Dermatology, Medical University of Warsaw, 02-006 Warsaw, Poland
3 shared publications - Anna Waśkiel-Burnat
Department of Dermatology Medical University of Warsaw Warsaw Poland
2 shared publications - Adriana Rakowska
Department of Dermatology, Medical University of Warsaw, Koszykowa 82A, 02-008 Warsaw, Poland
1 shared publication - Jadwiga Turło
Department of Drug Technology and Pharmaceutical Biotechnology, Medical University of Warsaw, 1 Banacha Str., 02-097 Warszawa, Poland
1 shared publication - Małgorzata Maj
Medical University of Warsaw
1 shared publication
Latest Publications
- 12 August 2022
- Published by Springer Nature
- p. 15-18
A 2-Month-Old Boy with a Pigment Lesion on the Scalp
- 12 August 2022
- Published by Springer Nature
- p. 15-18
A 2-Month-Old Boy with a Pigment Lesion on the Scalp
- 12 August 2022
- Published by Springer Nature
- p. 35-38
A 33-Year-Old Woman with Brain Metastases of Unknown Origin and a Melanotic Lesion on the Scalp
- 12 August 2022
- Published by Springer Nature
- p. 35-38
A 33-Year-Old Woman with Brain Metastases of Unknown Origin and a Melanotic Lesion on the Scalp
- Open Access
- 28 November 2021
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (23) , 5589
Efficacy and Safety of Different Formulations of Calcipotriol/Betamethasone Dipropionate in Psoriasis: Gel, Foam, and Ointment
Preparations containing calcipotriol combined with betamethasone dipropionate (in the forms of ointment, gel, and foam) are available for the topical treatment of psoriasis. This review summarizes the differences in the efficacy and safety of these formulations, as well as the preferences of patients with various forms of psoriasis (plaque, scalp, and nail psoriasis). It has been documented that foams provide higher bioavailability, resulting in increased efficacy in plaque psoriasis compared to ointments and gels. Gels or foams are preferred by patients for their different practical qualities (e.g., gels for “easy application”, and foams for “immediate relief”). The available data indicate that ointments may be the most effective formulation in nail psoriasis, and gels are preferred by patients with scalp psoriasis because of their cosmetic features. Treatment with a foam formulation is associated with a lower number of medical appointments compared to treatment with an ointment and with a lower probability of developing indications for systemic treatment. The safety profiles of foams, ointments, and gels are comparable, with the most common adverse effect being pruritus at the application site (in 5.8% of the patients). A long-term proactive maintenance therapy markedly reduces the number of relapses and is likely to close the gap between topical and systemic treatment in psoriasis.
- 28 November 2021
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (23) , 5589
Open AccessEfficacy and Safety of Different Formulations of Calcipotriol/Betamethasone Dipropionate in Psoriasis: Gel, Foam, and Ointment
Preparations containing calcipotriol combined with betamethasone dipropionate (in the forms of ointment, gel, and foam) are available for the topical treatment of psoriasis. This review summarizes the differences in the efficacy and safety of these formulations, as well as the preferences of patients with various forms of psoriasis (plaque, scalp, and nail psoriasis). It has been documented that foams provide higher bioavailability, resulting in increased efficacy in plaque psoriasis compared to ointments and gels. Gels or foams are preferred by patients for their different practical qualities (e.g., gels for “easy application”, and foams for “immediate relief”). The available data indicate that ointments may be the most effective formulation in nail psoriasis, and gels are preferred by patients with scalp psoriasis because of their cosmetic features. Treatment with a foam formulation is associated with a lower number of medical appointments compared to treatment with an ointment and with a lower probability of developing indications for systemic treatment. The safety profiles of foams, ointments, and gels are comparable, with the most common adverse effect being pruritus at the application site (in 5.8% of the patients). A long-term proactive maintenance therapy markedly reduces the number of relapses and is likely to close the gap between topical and systemic treatment in psoriasis.